RhumbLine Advisers’s Biohaven BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.45M Buy
164,749
+27,866
+20% +$300K ﹤0.01% 1843
2026
Q1
$1.16M Buy
136,883
+20,286
+17% +$222K ﹤0.01% 2122
2025
Q4
$1.32M Sell
116,597
-17,323
-13% -$215K ﹤0.01% 2084
2025
Q3
$2.01M Sell
133,920
-3,484
-3% -$50.7K ﹤0.01% 1913
2025
Q2
$1.94M Buy
137,404
+12,565
+10% +$224K ﹤0.01% 1903
2025
Q1
$3M Buy
124,839
+7,244
+6% +$255K ﹤0.01% 1612
2024
Q4
$4.39M Buy
117,595
+14,407
+14% +$672K ﹤0.01% 1488
2024
Q3
$5.16M Sell
103,188
-4,926
-5% -$192K ﹤0.01% 1412
2024
Q2
$3.75M Sell
108,114
-4,178
-4% -$165K ﹤0.01% 1550
2024
Q1
$6.14M Buy
112,292
+2,987
+3% +$148K 0.01% 1306
2023
Q4
$4.68M Buy
109,305
+14,029
+15% +$436K ﹤0.01% 1463
2023
Q3
$2.48M Sell
95,276
-113
-0.1% -$2.35K ﹤0.01% 1755
2023
Q2
$2.28M Buy
95,389
+4,198
+5% +$72.3K ﹤0.01% 1826
2023
Q1
$1.25M Buy
91,191
+11,769
+15% +$187K ﹤0.01% 2030
2022
Q4
$1.1M Buy
+79,422
New +$1.12M ﹤0.01% 2077

Other funds holding BHVN

RhumbLine Advisers's BHVN Position: Q2 2026 in Review

RhumbLine Advisers increased its Biohaven (BHVN) stake by 20% in Q2 2026, buying an estimated $300K and bringing the position to 164,749 shares worth $2.45M. The position accounts for ﹤0.01% of the portfolio, ranked #1843.

RhumbLine Advisers first reported a position in BHVN in Q4 2022 and has held it in 15 quarters since. The position peaked at $6.14M in Q1 2024. 296 funds tracked by Wall St. Rank hold BHVN as of Q2 2026.

  • RhumbLine Advisers held 164,749 shares of Biohaven worth $2.45M as of Q2 2026.
  • RhumbLine Advisers bought 27,866 Biohaven shares in Q2 2026, an estimated $300K.
  • Biohaven made up ﹤0.01% of RhumbLine Advisers's portfolio in Q2 2026, its #1843 holding.
  • RhumbLine Advisers first reported a position in Biohaven in Q4 2022 and has held it in 15 quarters since.
  • RhumbLine Advisers's Biohaven position peaked at $6.14M in Q1 2024.
  • 296 funds tracked by Wall St. Rank held Biohaven as of Q2 2026.

Based on RhumbLine Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.